SOD1 and amyotrophic lateral sclerosis: Based on the IPA-identified SOD1-ALS pathway molecules, it can be assumed that SOD1-induced toxicity in ALS is accompanied by aggregation of other misfolded proteins, lipid dysregulation, impaired neurotransmission, compromised vesicular transport, and perturbed cytoskeleton dynamics.